Manulife (Manufacturers Life Insurance)’s Spyre Therapeutics SYRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.2M | Buy |
79,896
+25,995
| +48% | +$389K | ﹤0.01% | 1736 |
|
|
2025
Q1 | $870K | Buy |
53,901
+1,139
| +2% | +$18.4K | ﹤0.01% | 1876 |
|
|
2024
Q4 | $1.23M | Buy |
52,762
+9,302
| +21% | +$217K | ﹤0.01% | 1808 |
|
|
2024
Q3 | $1.28M | Buy |
43,460
+5,678
| +15% | +$167K | ﹤0.01% | 1789 |
|
|
2024
Q2 | $888K | Buy |
37,782
+13,125
| +53% | +$309K | ﹤0.01% | 1922 |
|
|
2024
Q1 | $935K | Buy |
+24,657
| New | +$935K | ﹤0.01% | 1893 |
|
|
2022
Q2 | – | Sell |
-467
| Closed | -$26.9K | – | 3132 |
|
|
2022
Q1 | $26.9K | Sell |
467
-339
| -42% | -$19.5K | ﹤0.01% | 3055 |
|
|
2021
Q4 | $96 | Sell |
806
-207
| -20% | -$25 | ﹤0.01% | 3058 |
|
|
2021
Q3 | $201K | Sell |
1,013
-48
| -5% | -$9.52K | ﹤0.01% | 2985 |
|
|
2021
Q2 | $185K | Sell |
1,061
-103
| -9% | -$18K | ﹤0.01% | 3149 |
|
|
2021
Q1 | $230K | Sell |
1,164
-1
| -0.1% | -$198 | ﹤0.01% | 2806 |
|
|
2020
Q4 | $229K | Buy |
1,165
+135
| +13% | +$26.5K | ﹤0.01% | 2695 |
|
|
2020
Q3 | $183K | Hold |
1,030
| – | – | ﹤0.01% | 2606 |
|
|
2020
Q2 | $236K | Buy |
1,030
+287
| +39% | +$65.8K | ﹤0.01% | 2413 |
|
|
2020
Q1 | $87K | Buy |
743
+47
| +7% | +$5.5K | ﹤0.01% | 2617 |
|
|
2019
Q4 | $133K | Sell |
696
-89
| -11% | -$17K | ﹤0.01% | 2722 |
|
|
2019
Q3 | $150K | Buy |
785
+4
| +0.5% | +$764 | ﹤0.01% | 2707 |
|
|
2019
Q2 | $134K | Buy |
+781
| New | +$134K | ﹤0.01% | 2814 |
|
|
2018
Q3 | – | Sell |
-550
| Closed | -$145K | – | 3794 |
|
|
2018
Q2 | $145K | Buy |
+550
| New | +$145K | ﹤0.01% | 3314 |
|